WHO should accelerate, not stall, rectal artesunate deployment for pre-referral treatment of severe malaria
The recent World Health Organization moratorium on rectal artesunate (RAS) for pre-referral treatment of severe childhood malaria is costing young lives. The decision was based on disappointing findings from a large observational study that provided RAS to community health workers with little traini...
Auteurs principaux: | Peto, TJ, Watson, JA, White, NJ, Dondorp, AM |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Oxford University Press
2023
|
Documents similaires
-
Rectal artesunate suppositories for the pre-referral treatment of suspected severe malaria
par: Watson, JA, et autres
Publié: (2023) -
The CARAMAL study could not assess the effectiveness of rectal artesunate in treating suspected severe malaria
par: Watson, JA, et autres
Publié: (2023) -
Rectal artesunate: lives not saved
par: White, NJ, et autres
Publié: (2024) -
Rectal artesunate suppositories for the pre-referral treatment of suspected severe malaria.
par: James A Watson, et autres
Publié: (2023-11-01) -
Stopping prereferral rectal artesunate - a grave error
par: Watson, JA, et autres
Publié: (2022)